![]() |
市場調查報告書
商品編碼
1830967
膝關節植入物市場Knee Implant Market |
膝關節植入物市場規模預計將從 2024 年的 142.4 億美元增加到 2031 年的 198 億美元,2025 年至 2031 年的預估複合年成長率為 4.82%。
市場洞察與分析師觀點:膝關節植入物市場預測為利害關係人制定成長策略提供了寶貴的洞見。膝關節植入物(或稱假體)是一種用於替換受損或患病膝關節的醫療器材。它在膝關節置換手術中發揮著至關重要的作用,旨在緩解疼痛、恢復功能並增強患有晚期關節炎、嚴重膝關節損傷或其他退化性膝關節疾病患者的活動能力。通常,膝關節植入物由金屬合金、高品質聚合物(有時也包括陶瓷)製成,旨在模擬膝關節的自然功能。
成長動力與挑戰:目前膝關節植入物市場的趨勢表明,骨關節炎的盛行率和膝關節損傷率都在上升。骨關節炎是最常見的關節炎類型,其發生率顯著上升,尤其是在老年人和肥胖者中。這一趨勢凸顯了對膝關節植入手術日益成長的需求,這些手術旨在緩解疼痛、恢復活動能力並提高患者的生活品質。根據美國衛生指標與評估研究所 (IHS) 的數據,到 2050 年,全球將有約 10 億人患有骨關節炎,目前 30 歲及以上人群中約有 15% 患有骨關節炎。
手部和膝蓋是骨關節炎最常見的部位,預計到 2050 年,手部病例將增加 50%,膝蓋病例將增加 75%。此外,膝蓋受傷的數量不斷增加,尤其是在運動員和活躍人群中,這進一步推動了對膝關節植入物的需求,以解決創傷相關的關節損傷。
然而,骨科手術的高昂費用和有限的供應量對膝關節植入物市場的成長構成了挑戰。包括膝關節植入物在內的骨科手術高昂的費用可能會限制經濟困難或醫療資源匱乏地區的患者獲得治療。此外,骨科手術所需的大量培訓、專業知識和基礎設施,以及膝關節植入物手術的複雜性,導致某些地區出現了熟練骨科醫生的短缺。這種短缺可能導致骨科手術的等待時間過長,影響患者獲得治療的機會和醫療保健服務。
策略洞察報告細分和範圍:「膝關節植入物市場分析」考慮了多個細分市場:手術類型、植入物類型、材料和最終用戶。市場依手術類型分為全膝關節置換術、部分膝關節置換術及膝關節翻修置換術。依植入物類型分為固定軸承假體和活動軸承假體。依材料分為全骨水泥型和非骨水泥型。依最終使用者分為醫院、門診手術中心等。報告按地理分類,將膝關節植入物市場細分為北美(美國、加拿大和墨西哥)、歐洲(英國、德國、法國、義大利、西班牙和歐洲其他地區)、亞太地區(中國、日本、印度、澳洲、韓國和亞太其他地區)、中東和非洲(阿拉伯聯合大公國、沙烏地阿拉伯、南非和中東和非洲其他地區)以及南美洲和中美洲(巴西、阿根廷和中美洲(巴西和其他地區)。
細分分析:膝關節植入物市場報告根據手術類型將市場分為全膝關節置換術、部分膝關節置換術和膝關節翻修置換術。全膝關節置換術 (TKR) 細分市場在 2022 年佔據了最大的收入佔有率,這得益於製造商提供的植入物和客製化置換系統需求的不斷成長。這一顯著的市場佔有率也可歸因於大量的關節炎患者和越來越多的接受該手術的人數。在預測期內,預計部分膝關節置換術將以最快的速度成長。
根據植入物類型,市場分為固定軸承假體和活動軸承假體。 2022年,固定軸承假體市場佔據了較大的收入佔有率。然而,由於活動軸承假體耐磨性和穩定性的提升,預計在預測期內將以更快的複合年成長率成長。例如,捷邁邦美公司 (Zimmer Biomet) 推出了 NexGen LPS-Flex Mobile 和 LPS-Mobile Bearing 膝關節假體,術後可進行 25° 的無限制內旋或外旋。
就終端用戶而言,膝關節植入物市場細分為醫院、門診手術中心和其他。醫院憑藉其先進的技術和高技能的醫療專業人員,承擔了大部分膝關節置換手術,使其成為膝關節植入物市場中最大的細分市場。此外,患者對提供優質術後護理的醫院的偏好日益成長,預計將在預測期內支撐市場成長。
區域分析:從地理上看,膝關節植入物市場分為北美、歐洲、亞太、中東和非洲以及南美和中美。
北美在膝關節植入物市場收入方面領先,這主要歸因於美國膝關節置換手術的發生率較高。造成這現象的因素包括事故發生率的上升以及患有退化性疾病的人數的增加。加拿大衛生資訊研究所的報告顯示,2020年加拿大進行了約75,073例膝關節置換手術,加拿大每年在膝關節置換手術上的支出超過14億美元。然而,在新冠疫情封鎖期間,該地區的殘疾人群體面臨巨大的挑戰。
美國膝關節置換市場正在擴張,這得益於多種因素,包括新產品的推出、製造商的高度集中以及領先競爭對手之間的合作與收購。關鍵參與者的策略佈局使美國成為膝關節植入物成長的關鍵市場。例如,2021年11月,美國私人公司OrthAlign推出了Lantern,這是一款用於膝關節置換手術的手持式智慧儀器,只需一次使用即可為每位患者提供精確的客製化矯正。此類持續的產品創新預計將推動美國市場的成長。
膝關節植入物市場報告範圍產業發展與未來機會:全球膝關節植入物市場主要參與者的關鍵措施包括:
2023年10月,Medacta Group SA推出了首款針對KA最佳化的全膝關節置換股骨組件GMK SpheriKA。這家瑞士公司為運動醫學、脊椎外科和關節置換提供創新、客製化和永續的解決方案。 2021年11月,Zimmer Biomet Holdings, Inc.的Persona OsseoTi Keel Tibia獲得美國FDA 510(k)批准,可用於美國進行非骨水泥膝關節置換。競爭格局和主要公司:膝關節植入物市場的主要公司包括Zimmer Biomet、CONMED、Stryker、Smith and Nephew、DePuy Synthes、Aesculap Implants Systems, LLC、Medacta、Exactech, Inc.、MicroPort Scientific、Kinamed, Inc.、ConforMIS和OMNIlife science, Inc.。這些公司專注於擴大產品供應以滿足日益成長的全球消費者需求,利用其國際影響力服務廣泛的客戶群並擴大市場覆蓋範圍。
The knee implant market size is expected to increase from US$ 14.24 billion in 2024 to US$ 19.80 billion by 2031, with a projected CAGR of 4.82% from 2025 to 2031.
Market Insights and Analyst View:The forecast for the knee implant market provides valuable insights for stakeholders to strategize their growth. A knee implant, or prosthesis, is a medical device designed to replace a damaged or diseased knee joint. It plays a vital role in knee replacement surgery, aimed at relieving pain, restoring function, and enhancing mobility for individuals suffering from advanced arthritis, severe knee injuries, or other degenerative knee conditions. Typically, knee implants are made from metal alloys, high-quality polymers, and sometimes ceramic materials, designed to mimic the natural function of the knee joint.
Growth Drivers and Challenges:Current trends in the knee implant market show an increase in the prevalence of osteoarthritis and a rise in knee injuries. Osteoarthritis, the most common form of arthritis, has seen a significant rise, especially among older adults and those with obesity. This trend highlights the increasing demand for knee implant surgeries to relieve pain, restore mobility, and enhance the quality of life for those affected. According to the Institute for Health Metrics and Evaluation, by 2050, approximately 1 billion people globally will have osteoarthritis, with 15% of individuals aged 30 and older currently affected.
The hands and knees are the most common areas for osteoarthritis, with projections indicating a 50% increase in hand cases and a 75% increase in knee cases by 2050. Additionally, the growing number of knee injuries, particularly among athletes and active individuals, has further driven the demand for knee implants to address trauma-related joint damage.
However, the high costs associated with orthopedic procedures and limited availability pose challenges to the growth of the knee implant market. The significant expenses related to orthopedic surgeries, including knee implant procedures, can limit access for patients with financial constraints or those in underserved regions. Moreover, the extensive training, expertise, and infrastructure required for orthopedic surgeries, along with the complexity of knee implant procedures, have resulted in a shortage of skilled orthopedic surgeons in certain areas. This scarcity can lead to long waiting times for orthopedic procedures, affecting patient access and healthcare delivery.
Strategic Insights
Report Segmentation and Scope:The "knee implant market analysis" has been conducted considering various segments: by type of procedures, implant type, material, and end user. The market is categorized by procedure type into total knee replacement, partial knee replacement, and revision knee replacement. By implant type, it is divided into fixed-bearing prostheses and mobile-bearing prostheses. In terms of material, the market is segmented into total cemented and non-cemented. By end user, the market includes hospitals, ambulatory surgical centers, and others. Geographically, the report segments the knee implant market into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:The knee implants market report categorizes the market based on procedure type into total knee replacement, partial knee replacement, and revision knee replacement. The Total Knee Replacement (TKR) segment captured the largest revenue share in 2022, driven by the increasing demand for implants and customized replacement systems offered by manufacturers. This significant market share can also be attributed to a large patient population suffering from arthritis and a growing number of individuals undergoing the procedure. During the forecast period, partial knee replacement is expected to grow at the fastest rate.
By implant type, the market is divided into fixed-bearing prostheses and mobile-bearing prostheses. In 2022, the fixed-bearing prosthesis segment held a larger revenue share. However, the mobile-bearing prosthesis segment is anticipated to grow at a faster CAGR during the forecast period due to its improved wear properties and stability. For example, Zimmer Biomet offers NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knees, which allow for unrestricted internal or external rotation of 25° post-surgery.
In terms of end user, the knee implant market is segmented into hospitals, ambulatory surgical centers, and others. Hospitals perform the majority of knee replacement surgeries due to their access to advanced technologies and highly skilled healthcare professionals, making this segment the largest in the knee implant market. Additionally, the growing preference of patients for hospitals that provide significant post-surgical care is expected to support market growth during the forecast period.
Regional Analysis:Geographically, the knee implant market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
North America leads the knee implant market in terms of revenue, primarily due to a higher incidence of knee replacements in the US. Contributing factors include an increase in accident cases and a rise in the number of individuals with degenerative diseases. A report from the Canadian Institute for Health Information indicated that approximately 75,073 knee replacements were performed in Canada in 2020, with Canada spending over US$ 1.4 billion annually on knee replacement surgery. However, the disabled population in the region faced significant challenges during the COVID-19 pandemic lockdown.
The US knee replacement market is expanding due to several factors, including new product launches, a high concentration of manufacturers, and partnerships and acquisitions among leading competitors. The strategic presence of key players positions the US as a crucial market for knee implant growth. For instance, in November 2021, OrthAlign, a US-based private company, launched the Lantern, a handheld smart instrument for knee replacement surgery that provides precise, customized alignment for each patient with a single use. Such ongoing product innovations are expected to drive market growth in the country.
Knee Implant Market Report Scope
Industry Developments and Future Opportunities:Key initiatives by major players in the global knee implant market include:
In October 2023, Medacta Group S.A. launched the first KA-optimized femoral component for total knee replacement, GMK SpheriKA. This Swiss company provides innovative, customized, and sustainable solutions for sports medicine, spine surgery, and joint replacement.
In November 2021, Zimmer Biomet Holdings, Inc. received FDA 510(k) clearance for the Persona OsseoTi Keel Tibia for cementless knee replacement in the US.
Competitive Landscape and Key Companies:Key companies in the knee implant market include Zimmer Biomet, CONMED, Stryker, Smith and Nephew, DePuy Synthes, Aesculap Implants Systems, LLC, Medacta, Exactech, Inc., MicroPort Scientific, Kinamed, Inc., ConforMIS, and OMNIlife science, Inc. These companies are focused on expanding their product offerings to meet the increasing global consumer demand, leveraging their international presence to serve a wide customer base and enhance their market reach.